A case decades in the making: Barron vs. Tour
1987 – As an 18-year-old freshman at LSU, Barron is diagnosed with mitral valve prolapse and is prescribed medication commonly known as a beta blocker.
1995 – Plays in 21 events on the Nationwide Tour, making 11 cuts and finishing 103rd on the money list, with $14,773.
December 1995 – Misses the cut in the final stage of Q-School.
June 1996 – Plays in the FedEx St. Jude Classic, his first PGA Tour event as a professional, and misses the cut.
1996 – Earns $43,433 to finish 47th on the Nationwide Tour money list.
December 1996 – Qualifies for the PGA Tour, finishing third in Q-School.
1997 – Keeps his Tour card by finishing 116th on the money list, with $198,051.
1998-2000 – Keeps his card, ranking 108-123 on the money list.
2001 – Loses his card and fails to regain it at Q-School, finishing T-37th.
2002 – Plays his way back onto Tour, placing third on Nationwide money list, with $248,175.
2003 – It’s back to Q-School after a 167th-place finish, with $224,589.
December 2003 – Misses card with a T-155th at Q-School.
2004 – Finishes 29th on Nationwide money list, with $175,591.
December 2004 – A T-26th in Q-School merits his card.
May 2005 – Posts highest finish in a Tour event, T-3 at the EDS Byron Nelson Championship.
Fall 2005 – Diagnosed with low testosterone and is prescribed monthly doses of exogenous testosterone; misses the last four cuts of the year.
2005 – Keeps his card, ranking 110th with $731,990.
2006 – Surrenders card by earning $388,226 to rank 164th.
June 23 or 28*, 2008 – Applies for TUEs for the beta blocker Propranolol and exogenous testosterone. (* The Tour and Barron have different dates for the application.)
July 3, 2008 – Tour enacts anti-doping policy, with both of Barron’s medications on the banned list.
October 2008 – Stops taking monthly does of exogenous testosterone.
Oct 10, 2008 – Tour denies the TUE for Propranolol; Barron appeals.
Oct. 22, 2008 – Commissioner Tim Finchem denies appeal and instructs Barron to begin weaning himself off the drug.
2008 – Barron earns only $33,446 in 17 events on the Nationwide Tour.
Jan. 20 or 21*, 2009 – Tour denies the TUE for exogenous testosterone and instructs Barron to stop taking the drug. (* The Tour and Barron have different dates for the decision.)
Spring – Barron starts to take Lyrica as a substitute for Propranolol.
Early June – A doctor injects Barron with exogenous testosterone.
June 11 – Barron is drug-tested at the St. Jude Classic.
June 15 – Barron misses the cut at St. Jude.
2009 – Barron’s sample is found to contain Propranolol and testosterone.
July 23, Aug. 12 – Barron provides additional information to the Tour about his use of Propranolol and testosterone.
Oct. 20 – The Tour suspends Barron for one year (until Sept. 20, 2010) for violating the anti-doping ban on performance-enhancing drugs.
Nov. 12 – Barron files suit in the Chancery Court of Tennessee for monetary damages and injunctive relief.
Nov. 12 – Tour requests the case be moved to the U.S. District Court in the Western District of Tennessee.
Nov. 13 – Barron vs. PGA Tour is heard.
Nov. 16 – U.S. Magistrate Judge Tu Pham denies Barron’s request for a temporary restraining order against the Tour.
Gleneagles' 17th wreaks havoc in Open qualifier
Mickelson commits to FedEx St. Jude Classic
Bae withdraws from Open Championship qualifier
Bae, McDowell move up in OWGR after victories
Just say 'no' to make-up between Woods, Garcia
Print
Email
